On the House Health and Human Services Engrossed bill, delete everything after the enacting clause and insert:
"
Section 1. That § 34-20G-92 be AMENDED:
34-20G-92.
The Executive
Board of the Legislative Research Council shall appoint an oversight
committee
comprised of: one member of the House of Representatives, one member
of the Senate, one Division of Criminal Investigation agent, one
staff member from the Office of the Attorney General, two
representatives of law enforcement, one representative from the
department, one practitioner with experience in medical cannabis
issues, one nurse, one board member or principal officer of a
cannabis testing facility, one person with experience in policy
development or implementation in the field of medical cannabis, and
three qualifying patients
consisting of:
(1) Two members of the Senate;
(2) Two members of the House of Representatives;
(3) A physician licensed in accordance with chapter 36-4;
(4) A physician assistant licensed in accordance with chapter 36-4A;
(5) A certified nurse practitioner licensed in accordance with chapter 36-9A;
(6) A pharmacist licensed in accordance with chapter 36-11;
(7) The chief of police for a municipality having a population in excess of twenty-thousand;
(8) The chief of police for a municipality having a population of twenty-thousand or less; and
(9) A professional counselor licensed in accordance with chapter 36-32 or an addiction counselor licensed in accordance with chapter 36-34.
Section 2. That § 34-20G-93 be AMENDED:
34-20G-93. The oversight committee shall meet at least two times per year for the purpose of evaluating and making recommendations to the Legislature and the department regarding:
(1) The ability of qualifying patients in all areas of the state to obtain timely access to high-quality medical cannabis;
(2) The effectiveness of the dispensaries and cultivation facilities, individually and together, in serving the needs of qualifying patients, including the provision of educational and support services by dispensaries, the reasonableness of their prices, whether they are generating any complaints or security problems, and the sufficiency of the number operating to serve the state's registered qualifying patients;
(3) The effectiveness of the cannabis testing facilities, including whether a sufficient number are operating;
(4) The sufficiency of the regulatory and security safeguards contained in this chapter and adopted by the department to ensure that access to and use of cannabis cultivated is provided only to cardholders;
(5) Any recommended additions or revisions to the department regulations or this chapter, including relating to security, safe handling, labeling, and nomenclature; and
(6) Any research studies regarding health effects of medical cannabis for patients.
The oversight committee shall ensure that it seeks relevant input from qualifying patients; designated caregivers; school boards and administrators; parents; municipal representatives; state agencies, including the Department of Health, the South Dakota Division of Criminal Investigation, and the Department of Public Safety; and medical cannabis establishments."